ArticleJournal of natural medicines2025
Extraction, characterization, and biological activities of a novel polysaccharide extract from Fructus caryophylli.
Article in Journal of natural medicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study showed that Polysaccharide-rich Fructus caryophylli extracts (FCE) were prepared for investigation through hot water extraction. Glucose was found to be the significant monosaccharide by chemical analysis, which included Fourier transform-infrared (FT-IR), high-performance liquid chromatography (HPLC), and high-performance gel permeation chromatography (HPGPC). The average molecular weight of FCE was ranged from 15.19 and 208.53 kDa. The bioactivities of FCE, including antioxidant, whitening, tissue regeneration, and anti-wrinkle properties, were evaluated using both in vitro and in vivo tests. In vitro antioxidant experiments demonstrated scavenging of 1,1-Diphenyl-2-picrylhydrazyl (DPPH), 2,2'-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), hydroxyl radicals, and strong reducing power. FCE treatment effectively reduced oxidative stress in an in vivo antioxidant experiment involving zebrafish embryos exposed to a nonlethal dose of LPS, demonstrating its potent antioxidant potential. Furthermore, FCE exhibited promise in decreasing tyrosinase activity and total melanin content in zebrafish embryos, while promoting the relative expression levels of the elastin-regulating gene Eln1 RNA and the collagen-related gene col1a1a, thereby facilitating the positive stimulation of wound healing. This research provides valuable insights into the development of FCE as a novel functional raw material for applications in the food and cosmetics industries.
Indexed as
Identifiers
40121584What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.